Search research articles
Contact Us
Filters
Showing results (461-470 of 541) with videos related to
Page
of 55
Sort By:
Pain
|
April 23, 2013
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations
Shannon M Smith, Anthony T Wang, Nathaniel P Katz, et al.
Annals of Neurology
|
August 10, 2013
Splicing biomarkers of disease severity in myotonic dystrophy
Masayuki Nakamori, Krzysztof Sobczak, Araya Puwanant, et al.
Neurology
|
October 13, 2020
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial
Chad Heatwole, Elizabeth Luebbe, Spencer Rosero, et al.
BMC Neurology
|
September 12, 2019
Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study
Samantha LoRusso, Nicholas E Johnson, Michael P McDermott, et al.
Oncotarget
|
February 11, 2017
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress
Adi Zipin-Roitman, Nasma Aqaqe, Muhammad Yassin, et al.
Journal of Sports Sciences
|
March 21, 2015
Hydration status affects mood state and pain sensation during ultra-endurance cycling
Nicole E Moyen, Matthew S Ganio, Lenny D Wiersma, et al.
Archives of Neurology
|
February 10, 2010
A randomized, placebo-controlled trial of latrepirdine in Huntington disease
Karl Kieburtz, Michael P McDermott, Tiffini S Voss, et al.
Journal of Pediatric Rehabilitation Medicine
|
July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy
Maria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.
The Journal of Pain
|
December 8, 2014
Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review
Andrew McKeown, Jennifer S Gewandter, Michael P McDermott, et al.
Neurology
|
June 27, 2025
Spinal Muscular Atrophy Functional Composite Score Revised (SMA-FCR) in Untreated and Nusinersen-Treated Patient Cohorts
Amy Pasternak, Michael P McDermott, Jacqueline Montes, et al.
Page
of 55
Search research articles
Search
Showing results (461-470 of 541) with videos related to
Sort By:
Page
of 55
Pain
|
April 23, 2013
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations
Shannon M Smith, Anthony T Wang, Nathaniel P Katz, et al.
Annals of Neurology
|
August 10, 2013
Splicing biomarkers of disease severity in myotonic dystrophy
Masayuki Nakamori, Krzysztof Sobczak, Araya Puwanant, et al.
Neurology
|
October 13, 2020
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial
Chad Heatwole, Elizabeth Luebbe, Spencer Rosero, et al.
BMC Neurology
|
September 12, 2019
Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study
Samantha LoRusso, Nicholas E Johnson, Michael P McDermott, et al.
Oncotarget
|
February 11, 2017
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress
Adi Zipin-Roitman, Nasma Aqaqe, Muhammad Yassin, et al.
Journal of Sports Sciences
|
March 21, 2015
Hydration status affects mood state and pain sensation during ultra-endurance cycling
Nicole E Moyen, Matthew S Ganio, Lenny D Wiersma, et al.
Archives of Neurology
|
February 10, 2010
A randomized, placebo-controlled trial of latrepirdine in Huntington disease
Karl Kieburtz, Michael P McDermott, Tiffini S Voss, et al.
Journal of Pediatric Rehabilitation Medicine
|
July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy
Maria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.
The Journal of Pain
|
December 8, 2014
Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review
Andrew McKeown, Jennifer S Gewandter, Michael P McDermott, et al.
Neurology
|
June 27, 2025
Spinal Muscular Atrophy Functional Composite Score Revised (SMA-FCR) in Untreated and Nusinersen-Treated Patient Cohorts
Amy Pasternak, Michael P McDermott, Jacqueline Montes, et al.
Page
of 55